Gene · 1285
Papers2,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A mouse model for X-linked Alport syndrome induced by Del-ATGG in the Col4a5 gene. | Front Med (Lausanne) | 2023 | 36968823 | PubTator, text mining | PubMed |
| Phosphate induces inflammation and exacerbates injury from cigarette smoke in the bronchial epithelium. | Sci Rep | 2023 | 36966182 | PubTator, text mining | PubMed |
| Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma. | Blood Cancer J | 2023 | 36959208 | PubTator, text mining | PubMed |
| A genome-wide association study identifies a possible role for cannabinoid signalling in the pathogenesis of diabetic kidney disease. | Sci Rep | 2023 | 36949158 | PubTator, text mining | PubMed |
| Whole exome sequencing and rare variant association study to identify genetic modifiers, KLF1 mutations, and a novel double mutation in Thai patients with hemoglobin E/beta-thalassemia. | Hematology | 2023 | 36939018 | PubTator, text mining | PubMed |
| Exome-First Strategy in Adult Patients With CKD: A Cohort Study. | Kidney Int Rep | 2023 | 36938085 | PubTator, text mining | PubMed |
| Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients. | Front Oncol | 2023 | 36937425 | PubTator, text mining | PubMed |
| Patient-derived podocyte spheroids reveal new insights into the etiopathogenesis of Alport syndrome. | Front Cell Dev Biol | 2023 | 36936689 | PubTator, text mining | PubMed |
| Kidney Disease Associated With Mono-allelic COL4A3 and COL4A4 Variants: A Case Series of 17 Families. | Kidney Med | 2023 | 36925663 | PubTator, text mining | PubMed |
| Molecular dynamics and minigene assay of new splicing variant c.4298-20T>A of COL4A5 gene that cause Alport syndrome. | Front Genet | 2023 | 36923787 | PubTator, text mining | PubMed |
| Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives. | Mol Cell Proteomics | 2023 | 36918099 | PubTator, text mining | PubMed |
| Rare Dysfunctional Complement Factor I Genetic Variants and Progression to Advanced Age-Related Macular Degeneration. | Ophthalmol Sci | 2023 | 36909148 | PubTator, text mining | PubMed |
| Nidogen-2 (NID2) is a Key Factor in Collagen Causing Poor Response to Immunotherapy in Melanoma. | Pharmgenomics Pers Med | 2023 | 36908806 | PubTator, text mining | PubMed |
| Imputation-powered whole-exome analysis identifies genes associated with kidney function and disease in the UK Biobank. | Nat Commun | 2023 | 36890159 | PubTator, text mining | PubMed |
| Genetic stratification reveals COL4A variants and spontaneous remission in Egyptian children with proteinuria in the first 2 years of life. | Acta Paediatr | 2023 | 36847718 | PubTator, text mining | PubMed |
| Prognostic roles of a novel basement membranes-related gene signature in lung adenocarcinoma. | Front Genet | 2023 | 36845403 | PubTator, text mining | PubMed |
| A founder COL4A4 pathogenic variant resulting in autosomal recessive Alport syndrome accounts for most genetic kidney failure in Romani people. | Front Med (Lausanne) | 2023 | 36844206 | PubTator, text mining | PubMed |
| miRNAs: The Road from Bench to Bedside. | Genes (Basel) | 2023 | 36833241 | PubTator, text mining | PubMed |
| Posterior corneal vesicle syndrome or posterior polymorphous corneal dystrophy? A case report of a heterozygous intronic variant in the COL4A3 gene. | J Fr Ophtalmol | 2023 | 36828726 | PubTator, text mining | PubMed |
| Exploration and validation of the influence of angiogenesis-related factors in aortic valve calcification. | Front Cardiovasc Med | 2023 | 36824454 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1285/papers?page=19